US 12,458,631 B2
Use of dihydroberberine or its derivatives for anti-glycation
Ronghua Yi, Nanjing (CN); Mingru Wang, Nanjing (CN); Shawn Wells, Lewisville, TX (US); and Kylin Liao, Nanjing (CN)
Assigned to NANJING NUTRABUILDING BIO-TECH CO., LTD., Nanjing (CN)
Filed by NANJING NUTRABUILDING BIO-TECH CO., LTD., Nanjing (CN)
Filed on Oct. 26, 2022, as Appl. No. 17/973,852.
Prior Publication US 2023/0133496 A1, May 4, 2023
Int. Cl. A61K 31/4375 (2006.01); A61P 3/08 (2006.01)
CPC A61K 31/4375 (2013.01) [A61P 3/08 (2018.01)] 8 Claims
 
1. A method for preventing or reducing degradation of collagen fibers in skin of an individual, the method comprising administration to the individual a composition comprising an effective amount of dihydroberberine or a pharmaceutically acceptable salt, acid, ester, analog or derivative thereof, wherein the dihydroberberine or the pharmaceutically acceptable salt, acid, ester, analog or derivative thereof is formulated in a facial mask composition, a functionalized cream composition, a functionalized essence, a skin care composition, or a make-up composition.